Frank Rimerman Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Frank Rimerman Advisors's BIIB Position: Q1 2026 in Review
Frank Rimerman Advisors increased its Biogen (BIIB) stake by 0.23% in Q1 2026, buying an estimated $2.21K and bringing the position to 5,194 shares worth $952K. The position accounts for 0.06% of the portfolio, ranked #250.
Frank Rimerman Advisors first reported a position in BIIB in Q4 2023 and has held it in 7 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Frank Rimerman Advisors held 5,194 shares of Biogen worth $952K as of Q1 2026.
- Frank Rimerman Advisors bought 12 Biogen shares in Q1 2026, an estimated $2.21K.
- Biogen made up 0.06% of Frank Rimerman Advisors's portfolio in Q1 2026, its #250 holding.
- Frank Rimerman Advisors first reported a position in Biogen in Q4 2023 and has held it in 7 quarters since.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.